Applied Therapeutics, Inc.
NASDAQ:APLT
0.86 (USD) • At close December 31, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Applied Therapeutics, Inc. |
Symbool | APLT |
Munteenheid | USD |
Prijs | 0.856 |
Beurswaarde | 99,624,007 |
Dividendpercentage | 0% |
52-weken bereik | 0.773 - 10.624 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Shoshana Shendelman Ph.D. |
Website | https://www.appliedtherapeutics.com |
An error occurred while fetching data.
Over Applied Therapeutics, Inc.
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)